Position in NERV
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$407,109
+$399,846 QoQ
Shares Held
67,570
+3639.3% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NERV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. NERV ranks #300 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in NERV
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $407,109 | 67,570 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $7,263 | 1,807 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $21 | 10 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,504 | 875 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,755 | 1,621 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $26 | 12 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $28,173 | 10,552 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $31 | 10 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $25 | 10 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $399 | 65 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $365 | 53 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,966 | 434 | Shares | Sole | 2023-08-11 | |
| 2022-09-30 | $52,906 | 5,732 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,870 | 565 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||